Green Valley Pharmaceutical

Company snapshot

Founded in 1997 and headquartered in Shanghai’s Zhangjiang Science City, Shanghai Green Valley Pharmaceuticals is an innovative Chinese pharmaceutical company that’s driven by research and innovation. The company now employs about 1,500 people. Green Valley is an innovative Chinese pharmaceutical company that pioneers new treatment strategies in the area of chronic and complex diseases. The compan

• 5 active pipeline program(s) linked via ClinicalTrials.gov.
• 5 trial update(s) in the last 12 months.

Public regulatory, clinical, patent, and corporate records for Green Valley Pharmaceutical. Not investment advice.

• What is Green Valley Pharmaceutical?

  Green Valley (Shanghai) is a pharma organization headquartered in CN. Primary therapeutic focus areas include Hepatitis B, Bacterial Infections, Thyroid Disease, Kawasaki Disease, Influenza. NovaPharmaNews links 5 clinical program(s), 0 drug profile(s), and 0 patent record(s) to

• Is Green Valley Pharmaceutical publicly traded?

  Green Valley Pharmaceutical appears in our database through regulatory marketing authorisation or clinical trial sponsor records; a US listed ticker is not shown for this entity.

• What drugs does Green Valley Pharmaceutical develop or market?

  We link 6 drug profile(s) where Green Valley Pharmaceutical is an originator or marketer in FDA or regional approval metadata. See the drug portfolio table on https://novapharmanews.com/companies/green-valley-shanghai-pharmaceuticals-co#company-drugs.

• What are the latest developments for Green Valley Pharmaceutical?

  In the last 12 months our linked public records show 5 trial program update(s) and 0 US patent grant(s) tied to this profile.

• What therapeutic areas does Green Valley Pharmaceutical focus on?

  Green Valley Pharmaceutical focuses on Hepatitis B, Bacterial Infections, Thyroid Disease based on our analysis of their pipeline programs and drug development activities.